207 related articles for article (PubMed ID: 15813835)
1. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study.
Domínguez-Muñoz JE; Iglesias-García J; Iglesias-Rey M; Figueiras A; Vilariño-Insua M
Aliment Pharmacol Ther; 2005 Apr; 21(8):993-1000. PubMed ID: 15813835
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
[TBL] [Abstract][Full Text] [Related]
3. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis.
Domínguez-Muñoz JE; Iglesias-García J; Vilariño-Insua M; Iglesias-Rey M
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):484-8. PubMed ID: 17445754
[TBL] [Abstract][Full Text] [Related]
4. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
Löser C; Fölsch UR
Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
[TBL] [Abstract][Full Text] [Related]
5. [Croatian guidelines for the management of pancreatic exocrine insufficiency].
Rustemović N; Krznarić Z; Bender DV; Ostojić R; Cavka SC; Milić S; Anić B; Ljubicić N; Mesarić J; Stimac D; ; ; ; ;
Lijec Vjesn; 2012; 134(5-6):141-7. PubMed ID: 22930931
[TBL] [Abstract][Full Text] [Related]
6. Maldigestion from pancreatic exocrine insufficiency.
Pongprasobchai S
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():99-102. PubMed ID: 24251713
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
Dutta SK; Rubin J; Harvey J
Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
[TBL] [Abstract][Full Text] [Related]
8. [Pancreatic extract therapy in exocrine pancreatic insufficiency].
Santini B; Ivaldi AP
Minerva Gastroenterol Dietol; 1993 Sep; 39(3):133-7. PubMed ID: 8286485
[TBL] [Abstract][Full Text] [Related]
9. Alipase versus nonenteric-coated enzymes in pancreatic insufficiency. A french multicenter crossover comparative study.
Gouerou H; Dain MP; Parrondo I; Poisson D; Bernades P
Int J Pancreatol; 1989; 5 Suppl():45-50. PubMed ID: 2702250
[TBL] [Abstract][Full Text] [Related]
10. [Experience with the use of 13C-breath test for the evaluation of the efficacy of enzyme substitution therapy with microencapsulated pancreatinin in patients with severe primary pancreatic insufficiency].
Rapoport SI; Maev IV; Kucheriavyĭ IuA; Shubina NA; Semenova NV; Stukova NIu; Archakov AI
Klin Med (Mosk); 2009; 87(1):53-7. PubMed ID: 19256262
[TBL] [Abstract][Full Text] [Related]
11. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment.
Bruno MJ; Haverkort EB; Tytgat GN; van Leeuwen DJ
Am J Gastroenterol; 1995 Sep; 90(9):1383-93. PubMed ID: 7661155
[TBL] [Abstract][Full Text] [Related]
12. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
Konstan MW; Stern RC; Trout JR; Sherman JM; Eigen H; Wagener JS; Duggan C; Wohl ME; Colin P
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1365-71. PubMed ID: 15606399
[TBL] [Abstract][Full Text] [Related]
13. Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey.
Sikkens EC; Cahen DL; van Eijck C; Kuipers EJ; Bruno MJ
Pancreatology; 2012; 12(1):71-3. PubMed ID: 22487479
[TBL] [Abstract][Full Text] [Related]
14. The effect of oral pancreatic enzyme supplementation on the course and outcome of acute pancreatitis: a randomized, double-blind parallel-group study.
Kahl S; Schütte K; Glasbrenner B; Mayerle J; Simon P; Henniges F; Sander-Struckmeier S; Lerch MM; Malfertheiner P
JOP; 2014 Mar; 15(2):165-74. PubMed ID: 24618443
[TBL] [Abstract][Full Text] [Related]
15. Study of the gastrointestinal bioavailability of a pancreatic extract product (Zenpep) in chronic pancreatitis patients with exocrine pancreatic insufficiency.
Lieb JG; Patel D; Karnik N; Toskes PP
Pancreatology; 2020 Sep; 20(6):1092-1102. PubMed ID: 32800653
[TBL] [Abstract][Full Text] [Related]
16. [Specificities of the diagnostics and therapy of exocrine pancreatic insufficiency].
Díté P; Novotny I; Kocna P; Bojková M; Kupka T; Nechutová H; Kianicka B
Vnitr Lek; 2013 Jan; 59(1):65-70. PubMed ID: 23565526
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic exocrine insufficiency: diagnostic evaluation and replacement therapy with pancreatic enzymes.
Hammer HF
Dig Dis; 2010; 28(2):339-43. PubMed ID: 20814209
[TBL] [Abstract][Full Text] [Related]
18. Exocrine pancreatic function after recovery from necrotizing pancreatitis.
Bozkurt T; Maroske D; Adler G
Hepatogastroenterology; 1995 Feb; 42(1):55-8. PubMed ID: 7782037
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?
Domínguez-Muñoz JE
Adv Med Sci; 2011; 56(1):1-5. PubMed ID: 21450558
[TBL] [Abstract][Full Text] [Related]
20. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
Gubergrits N; Malecka-Panas E; Lehman GA; Vasileva G; Shen Y; Sander-Struckmeier S; Caras S; Whitcomb DC
Aliment Pharmacol Ther; 2011 May; 33(10):1152-61. PubMed ID: 21418260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
